Denman accumulated heavily at higher prices, maximised their involvement in the capital raising and have subsequently continued to buy shares at market.
WCN is valued at under 3 million and l can see why Denman is determined to get to 19.99% stake in the company. Expect more Appendix 3B notices. I anticipate a takeover at fair value which is at multiples of where we are now.
- Forums
- ASX - By Stock
- WCN
- Denman takeover
Denman takeover
Add WCN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.9¢ |
Change
-0.002(9.52%) |
Mkt cap ! $32.58M |
Open | High | Low | Value | Volume |
2.1¢ | 2.1¢ | 1.9¢ | $77.88K | 3.863M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 2331227 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 4593531 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 76154 | 0.006 |
16 | 7323164 | 0.005 |
8 | 13050445 | 0.004 |
3 | 16130100 | 0.003 |
1 | 20000000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 2905714 | 3 |
0.008 | 1787144 | 5 |
0.009 | 1150000 | 2 |
0.010 | 2022249 | 5 |
0.011 | 2500000 | 1 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
WCN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
Previous Video
Next Video
SPONSORED BY The Market Online